HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lawmakers Ask Wyeth To Substantiate Centrum Cardio Cholesterol Claims

This article was originally published in The Tan Sheet

Executive Summary

The House Energy and Commerce Committee questions the cholesterol-lowering claims Wyeth makes for its Centrum Cardio multivitamin

You may also be interested in...



Science, FDA Rule Support Centrum Cardio Claims, Wyeth Will Tell Congress

Wyeth says both science and FDA support the claims for Centrum Cardio that the House Energy and Commerce Committee is questioning

New Products In Brief

Omega-3/vitamin K supplement: The first supplement in North America to combine omega-3 and vitamin K will launch under a partnership between Ocean Nutrition Canada, which markets the MEG-3 brand Omega-3 EPA/DHA products and PL Thomas, a New Jersey supplier of MenaQ7 Natural Vitamin K2, firms announce Nov. 5. "The many health benefits of EPA and DHA from fish oil are well recognized, and with this new offering, consumers specifically interested in cardiovascular health benefits will also receive natural vitamin K2 as MK-7, which is shown to further promote vascular health," ONC says. ONC said several of its customers are developing products combining Meg-3 and MenaQ7 in formulations targeting heart health...

FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down

FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137460

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel